Leveringen - 384844-2019

14/08/2019    S156    - - Leveringen - Aankondiging van een gegunde opdracht - Openbare procedure 

Denemarken-København Ø: Farmaceutische producten

2019/S 156-384844

Aankondiging van een gegunde opdracht

Resultaten van de aanbestedingsprocedure

Leveringen

Legal Basis:

Richtlijn 2014/24/EU

Afdeling I: Aanbestedende dienst

I.1)Naam en adressen
Amgros I/S
Dampfærgevej 22
København Ø
2100
Denemarken
Contactpersoon: Flemming Sonne
Telefoon: +45 88713000
E-mail: udbud@amgros.dk
Fax: +45 88713008
NUTS-code: DK0

Internetadres(sen):

Hoofdadres: http://www.amgros.dk

I.1)Naam en adressen
Landspítali
Eiríksgata 5
Reykjavík
101
IJsland
Contactpersoon: Hulda Harðardóttir
E-mail: huldahar@landspitali.is
NUTS-code: IS

Internetadres(sen):

Hoofdadres: http://www.rikiskaup.is

I.1)Naam en adressen
Sykehusinnkjøp HF, divisjon legemidler
Grev Wedels plass 7
Oslo
0151
Noorwegen
Contactpersoon: Eirik Sverrisson
E-mail: eirik.sverrisson@sykehusinnkjop.no
NUTS-code: NO

Internetadres(sen):

Hoofdadres: http://www.sykehusinnkjop.no

I.2)Inlichtingen betreffende gezamenlijke aanbesteding
De opdracht omvat een gezamenlijke aanbesteding
In geval van een gezamenlijke aanbesteding waar meerdere landen bij betrokken zijn – vermeld de toepasselijke nationale wetgeving op het gebied van aanbestedingen:

Danish law.

I.4)Soort aanbestedende dienst
Publiekrechtelijke instelling
I.5)Hoofdactiviteit
Gezondheid

Afdeling II: Voorwerp

II.1)Omvang van de aanbesteding
II.1.1)Benaming:

Joint Nordic Procurement of Pharmaceuticals — 2020 — NF 1.621.b

II.1.2)CPV-code hoofdcategorie
33600000
II.1.3)Type opdracht
Leveringen
II.1.4)Korte beschrijving:

Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals to the public hospitals and health authorities in the countries. In Denmark certain pharmaceuticals is resold to the Faroe Island and Greenland. For this procurement group delivery to Iceland is an option, see section II.2.11).

Tenders for the pharmaceuticals are invited so that the contracting authorities can enter into framework agreements for delivery of the pharmaceuticals requested in the list of products and specified under the various lots below (section II.2.4).

The framework agreements are non-exclusive to the supplier. The hospitals and health authorities are not obliged to use the framework agreement.

II.1.6)Inlichtingen over percelen
Verdeling in percelen: neen
II.1.7)Totale waarde van de aanbesteding (exclusief btw)
Waarde zonder btw: 5 990 000.00 EUR
II.2)Beschrijving
II.2.1)Benaming:
II.2.2)Aanvullende CPV-code(s)
II.2.3)Plaats van uitvoering
NUTS-code: DK
NUTS-code: IS
NUTS-code: NO
II.2.4)Beschrijving van de aanbesteding:

Procurement No 1

ATC Code: J01DH02

Generic name: Meropenem (Vial)

Pharmaceutical form: Powder for infusionfluid

Strength: 500 mg

Unit value: 3 g

Volume in units: (Norway: 3750)(Denmark: 6695)(Iceland: 19)

ATC Code: J01DH02

Generic name: Meropenem (Vial)

Pharmaceutical form: Powder for infusionfluid

Strength: 1 g

Unit value: 3 g

Volume in units: (Norway:65500)(Denmark:1784490)(Iceland:495)

Under the title ‘quantity in units’, an estimated consumption of the pharmaceuticals is indicated for each of the countries.

It should be noted that this estimate is based on historic consumption data and that the suppliers must expect that the actual purchase under a framework agreement may differ significantly from the estimate. Reference is made to paragraph 3.6 of the tender specifications and clause 2 of the framework agreement.

The supplier must have authorisation to produce, import or receive pharmaceuticals for wholesale distribution within the EU/EEA.

Marketing authorisations applicable for Denmark, Norway and Iceland must be in place for the pharmaceuticals in sufficient time to ensure that the pharmaceuticals appear in Medicinpriser.dk (Denmark), ‘Farmalogg’ (Norway) and ‘Lyfjaverðskrá’ (Iceland) no later than 1.12.2019. The requirement regarding ‘Lyfjaverðskrá’ (Iceland) only apply if Iceland is part of the framework agreement, see section II.2.11).

II.2.5)Gunningscriteria
Prijs
II.2.11)Inlichtingen over opties
Opties: ja
Beschrijving van opties:

Clause 1 of the framework agreement provides for an option for delivery in a pre-agreement period (i.e. before the purchase period begins) and an option for delivery in a post-agreement period (i.e. after the purchase period). The 2 options may be exercised on the terms and conditions stipulated in the framework agreement and in the tender specifications.

For this procurement group delivery to Iceland is an option. The supplier can choose to submit a tender for this option. If the supplier is awarded a framework agreement the framework agreement will cover delivery of the pharmaceuticals in all 3 countries for the purchase period.

If the supplier chooses not to give a tender for the delivery to Iceland the framework agreement will cover delivery of the pharmaceuticals in Denmark and Norway.

II.2.13)Inlichtingen over middelen van de Europese Unie
De aanbesteding houdt verband met een project en/of een programma dat met middelen van de EU wordt gefinancierd: neen
II.2.14)Nadere inlichtingen

Afdeling IV: Procedure

IV.1)Beschrijving
IV.1.1)Type procedure
Openbare procedure
IV.1.3)Inlichtingen over een raamovereenkomst of dynamisch aankoopsysteem
De aanbesteding betreft het sluiten van een raamovereenkomst
IV.1.6)Inlichtingen over elektronische veiling
IV.1.8)Inlichtingen over de Overeenkomst inzake overheidsopdrachten (GPA)
De opdracht valt onder de GPA: ja
IV.2)Administratieve inlichtingen
IV.2.1)Eerdere bekendmaking betreffende deze procedure
Nummer van de aankondiging in het PB S: 2019/S 072-169900
IV.2.8)Inlichtingen over de stopzetting van een dynamisch aankoopsysteem
IV.2.9)Inlichtingen over de stopzetting van een oproep tot mededinging in de vorm van een vooraankondiging

Afdeling V: Gunning van een opdracht

Benaming:

Joint Nordic Procurement of Pharmaceuticals — 2020 — NF 1.621.b

Een opdracht/perceel wordt gegund: ja
V.2)Gunning van een opdracht
V.2.1)Datum van de sluiting van de overeenkomst:
08/08/2019
V.2.2)Inlichtingen over inschrijvingen
Aantal inschrijvingen: 3
De opdracht is gegund aan een groep ondernemers: ja
V.2.3)Naam en adres van de contractant
Sun Pharmaceutical Germany GmbH
Leverkusen
Duitsland
NUTS-code: DE
De contractant is een mkb-bedrijf: neen
V.2.3)Naam en adres van de contractant
FrostPharma AB
Danderyd
Zweden
NUTS-code: SE
De contractant is een mkb-bedrijf: neen
V.2.3)Naam en adres van de contractant
Fresenius Kabi
København
Denemarken
NUTS-code: DK01
De contractant is een mkb-bedrijf: neen
V.2.4)Inlichtingen over de waarde van de opdracht/het perceel (exclusief btw)
Aanvankelijk geraamde totale waarde van de opdracht/het perceel: 6 000 000.00 EUR
Totale waarde van de opdracht/het perceel: 5 989 351.00 EUR
V.2.5)Inlichtingen over uitbesteding

Afdeling VI: Aanvullende inlichtingen

VI.3)Nadere inlichtingen:

This call for tenders is conducted as an open procedure in accordance with the Danish Procurement Act (udbudsloven). The procurement procedure is subject to Danish law and any complaints of the procurement procedure shall be lodged with the Danish Complaints Board for Public Procurement (Klagenævnet for udbud), see section VI.4).

In relation to section II.2.4) it should be noted that the contracting authorities has considered whether the procurement group can be subdivided. The contracting authorities has assessed that this is not the case on the basis of considerations of economies of scale which will not be realisable in case of a further subdivision, as well as costs and patient safety considerations related to the subsequent management of contract and pharmaceuticals.

In relation to sections II.1.5) and II.2.6) it should be noted that the estimated value indicated in section II.1.5) is the total estimated value of the procurement for the duration of the framework agreement, including the option of renewal, see section II.2.7). and based on the AIP (‘Apotekernes Indkøbspris’ published by the Danish Medicines Agency) of the Parmaceuticals. It should furthermore be noted that the estimated value is based on historic consumption data and that the actual purchase under a framework agreement may differ significantly from the estimate, see section II.2.4), paragraph 3.6 of the tender specifications and clause 2 of the framework agreement.

Questions concerning the tender documents must be submitted through the tendering system, see the provisions of the tender specifications in this regard.

The access to submit tender requires that the operator is registered as a user of Amgros' tendering system. The registration as a user may take a few days, and the tenderer must therefore make sure to register in good time. Reference is made to the information provided in the tendering system, including the user guide.

In relation to section VI.2) it should be noted that electronic invoicing is required.

VI.4)Beroepsprocedures
VI.4.1)Beroepsinstantie
Klagenævnet for Udbud
Nævnenes Hus, Toldboden 2
Viborg
8800
Denemarken
Telefoon: +45 35291095
E-mail: klfu@erst.dk

Internetadres: https://erhvervsstyrelsen.dk/klagenaevnet-for-udbud

VI.4.2)Voor bemiddelingsprocedures bevoegde instantie
VI.4.3)Beroepsprocedure
Precieze aanduiding van de termijn(en) voor beroepsprocedures:

Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act No 593 of 2.6.2016 as amended) the following deadlines apply to the lodging of complaints:

Complaints of the tendering procedure must be lodged with the complaints board for public procurement within 6 months after the contracting entity has entered into a framework agreement calculated from the day after the day when the contracting entity has notified the affected applicants and tenderers, see section 7(2), para.(3) of the Act. Not later than at the time of lodging a complaint with the Danish Complaints Board for Public Procurement, the complainant must notify the contracting authorities in writing that a complaint has been lodged with the Danish Complaints Board for Public Procurement and whether the complaint was lodged during the standstill period, see section 6(4) of the Act. In cases where the complaint was not lodged within the standstill period, the complainant must furthermore indicate whether a suspensory effect of the complaint has been requested, see clause 6(4) of the Act.

VI.4.4)Dienst waar inlichtingen over de beroepsprocedures kunnen worden verkregen
Konkurrence- og Forbrugerstyrelsen
Carl Jacobsens vej 35
Valby
2500
Denemarken
Telefoon: +45 41715000

Internetadres: http://www.kfst.dk

VI.5)Datum van verzending van deze aankondiging:
12/08/2019